Rates of proximal deep vein thrombosis as assessed by compression ultrasonography in patients receiving prolonged thromboprophylaxis with low molecular weight heparin after major orthopedic surgery

被引:12
|
作者
Schellong, S
Hesselschwerdt, HJ
Paar, WD
von Hanstein, KL
机构
[1] Tech Univ Dresden, Med Fac Carl Gustav Carus, Div Angiol, D-01307 Dresden, Germany
[2] Orthoped Rehabil Ctr, Bad Krozingen, Germany
[3] Sanofi Aventis Pharma Germany, Dept Med, Berlin, Germany
[4] ALKO Grp, Wiesbaden, Germany
关键词
ultrasonography; orthopedic surgery; venous thromboembolism; low-molecular-weight heparin;
D O I
10.1160/TH05-01-0077
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients undergoing major orthopedic surgery are at an increased risk of thromboembolism even after the acute postoperative phase. Therefore, prolonged thromboprophylaxis is currently recommended and widely used. The length of hospital stay after major orthopedic surgery is steadily decreasing and most patients are transferred to specialized rehabilitation centers in the early postoperative phase. Consequently, thromboprophylaxis is usually given during the rehabilitation period. Previously there have been no systematic studies of how many patients with asymptomatic thrombosis are transferred to a rehabilitation center or how many patients develop deep vein thrombosis (DVT) during rehabilitation. In the present study, 238 patients who had undergone major orthopedic surgery were examined by compression ultrasonography on day 1 or 2 and on day 20 of their rehabilitation phase in order to detect asymptomatic proximal DVT. Sonograms were read centrally with blinding to the clinical course of the patients. All patients received standard thromboprophylaxis during the acute postoperative phase. Prolonged thromboprophylaxis with enoxaparin was given during the rehabilitation phase. The mean duration of thromboprophylaxis was 36.8 days. At admission to the rehabilitation center, proximal DVT was identified in 16 patients (6.7%). New proximal DVT at discharge from the rehabilitation center was identified in 3.2% of patients following prolonged thromboprophylaxis with enoxaparin. In conclusion, a considerable percentage of patients with asymptomatic proximal DVT are transferred to rehabilitation centers following major orthopedic surgery. Using prolonged thromboprophylaxis, new proximal DVTs will still develop during rehabilitation, but at a low rate.
引用
收藏
页码:532 / 536
页数:5
相关论文
共 50 条
  • [21] Therapy of deep vein thrombosis with low molecular weight heparin, leg compression and immediate ambulation
    Partsch, H
    [J]. VASA-JOURNAL OF VASCULAR DISEASES, 2001, 30 (03): : 195 - 204
  • [22] The Use of Low Molecular Weight Heparin and Pneumatic Compression Devises for Deep Vein Thrombosis Prophylaxis in Major Trauma Patients: A Comparative Effectiveness Analysis
    Alahmari, Abdullah
    Almalki, Ziyad
    Jeff, Guo
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 358 - 359
  • [23] THE USE OF LOW MOLECULAR WEIGHT HEPARIN AND PNEUMATIC COMPRESSION DEVISES FOR DEEP VEIN THROMBOSIS PROPHYLAXIS IN MAJOR TRAUMA PATIENTS: A COMPARATIVE EFFECTIVENESS ANALYSIS
    Alahmari, A. K.
    Almalki, Z. S.
    Guo, J. J.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A132 - A132
  • [24] Decreased mortality in cancer patients treated for proximal deep vein thrombosis with low-molecular-weight heparin as compared with unfractionated heparin
    Pineo, GF
    Hull, RD
    Raskob, GE
    Brant, RF
    Green, D
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : O1566 - O1566
  • [25] Efficacy and safety of low molecular weight heparin (Enoxaparin) in patients with proximal deep vein thrombosis associated or not with pulmonary embolism
    Faivre, R
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 361A - 361A
  • [26] Cost-effectiveness of low-molecular-weight heparin in the treatment of proximal deep vein thrombosis
    Carlos A. Estrada
    Christopher J. Mansfield
    Gustavo R. Heudebert
    [J]. Journal of General Internal Medicine, 2000, 15 : 108 - 115
  • [27] Cost-effectiveness of low-molecular-weight heparin in the treatment of proximal deep vein thrombosis
    Estrada, CA
    Mansfield, CJ
    Heudebert, GR
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2000, 15 (02) : 108 - 115
  • [28] COMPARISON OF SUBCUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN WITH INTRAVENOUS STANDARD HEPARIN IN PROXIMAL DEEP-VEIN THROMBOSIS
    PRANDONI, P
    LENSING, AWA
    BULLER, HR
    CARTA, M
    COGO, A
    VIGO, M
    CASARA, D
    RUOL, A
    TENCATE, JW
    [J]. LANCET, 1992, 339 (8791): : 441 - 445
  • [29] US-Doppler monitoring of asymptomatic distal deep vein thrombosis in patients given low-molecular-weight heparin at prophylactic doses after orthopedic surgery.
    Barrellier, MT
    Le Hello, C
    Verfaille, M
    Vignon, C
    Bertin, T
    Boissel, M
    Dubois, F
    Fauchon, G
    Pegoix, M
    Thomassin, C
    Trahay, A
    Aubriot, JH
    Vielpeau, C
    [J]. JOURNAL DES MALADIES VASCULAIRES, 2000, 25 (03) : 195 - 200
  • [30] THROMBOPROPHYLAXIS BY LOW-MOLECULAR-WEIGHT HEPARIN - A RETROSPECTIVE STUDY ON 1123 PATIENTS FOLLOWING ORTHOPEDIC-SURGERY
    KUNZ, M
    HESS, H
    HILT, K
    [J]. MEDIZINISCHE WELT, 1995, 46 (11): : 550 - 554